As proof of principle demonstration, we investigated the expression of SR‐B1 and CCL5 in GBM samples and found that the protein levels of SR‐B1 and CCL5 were obviously elevated in tumor tissues versus in the peritumor tissues (Figure 1D–G; Figure S1, Supporting Information). This evidence concerns the gene CCL5 and glioblastoma.